Raymond F. Schinazi, Ph.D., Hon. DSc
Joined the amfAR board in November 2011. Expertise in antiviral agents and biotechnology. Best known for his pioneering work on six anti-HIV/HBV drugs that are now approved by the FDA or are at various stages of clinical development. More than 94 percent of HIV-infected individuals take at least one of the drugs he invented, and it is estimated that his work has saved more than four million lives worldwide.
Dr. Schinazi is the Frances Winship Walters Professor of Pediatrics and Director of the Laboratory of Biochemical Pharmacology at Emory University. He serves as the Senior Research Career Scientist at the Atlanta Department of Veterans Affairs and Director of the Scientific Working Group on Viral Eradication for the NIH-sponsored Emory University Center for AIDS Research. He has founded several biotechnology companies focusing on antiviral drug discovery and development, authored more than 460 peer-reviewed papers and seven books, and has served on the editorial board of numerous journals. In addition, he served on the Presidential Commission on AIDS and his pioneering work on HCV has led to the discovery and development of curative therapies for this devastating disease. In 2013, he joined the board of directors of the Vaccine & Gene Therapy Institute of Florida.
In January 2013 Dr. Schinazi was named a National Academy of Inventors Charter Fellow. Among his other recent honors are the Georgia Biomedical Industry Growth Award, the Bruce Witte Annual Distinguished Award and the 2006 Distinguished Scientist Award from the Hepatitis B Foundation, the Ewing Marion Kauffman Foundation’s Top Innovators in America Award, and two Merit Awards (10-year grants) from NIH-NIAID. In 2008, Dr. Schinazi was honored with the Dean’s Distinguished Faculty Lecture and Award at Emory University School of Medicine. In 2011, he was inducted into the Technology Hall of Fame of Georgia.
He lives in Miami, FL, Atlanta, GA, and Paris, France.